Rival Can't Shake AngioDynamics' $145M Racketeering Suit

By Chris Villani · September 26, 2019, 4:38 PM EDT

Medical device maker AngioDynamics Inc. can continue with its racketeering claims against a competitor, a Massachusetts judge ruled Wednesday, saying that its bid to recover $145 million in a judgment and...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum and Order

Case Information

Case Title

AngioDynamics, Inc. v. Wolfgang Neuberger, et al.,

Case Number

Court

Massachusetts

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

March 15, 2018

Recent Articles By Chris

July 12, 2024
Feds Say Fake Gunshot Wounds Part Of $1M Fraud Scheme
March 01, 2024
GSK, Shook Hardy Can Recover Costs After Zofran MDL Win
February 26, 2024
Teva Tells 1st Circ. Feds Must Clear High Bar In FCA Case
February 20, 2024
Justices Decline Malpractice Dispute Over $6M Settlement
December 21, 2023
The 5 Biggest First Circuit Rulings Of 2023
December 20, 2023
No Discovery In Regeneron FCA Case Until 1st Circ. Rules
November 21, 2023
Ex-Aegerion Rep Cops To Fraud, Avoiding Trial Redo
November 13, 2023
Florida Duo Cops To $1.5M Medicare Fraud In Ga. Court
November 13, 2023
Ex-Aegerion Rep. Strikes Deal To Avoid 2nd Fraud Trial
November 02, 2023
Firms Ask 1st Circ. To Force Ruling In Fee Row After 5 Years